{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T20:46:20Z","timestamp":1779223580805,"version":"3.51.4"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s11739-024-03710-8","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T03:40:21Z","timestamp":1723088421000},"page":"1959-1966","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Incidence and long-term outcomes of upper limb deep vein thrombosis associated with intracardiac devices: analysis of bleeding, recurrence, and sequelae"],"prefix":"10.1007","volume":"19","author":[{"given":"Marta-Olimpia","family":"Lago-Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8627-304X","authenticated-orcid":false,"given":"Marina","family":"L\u00f3pez-Rubio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Morag\u00f3n-Ledesma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Crhistian-Mario","family":"Oblitas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Galeano-Valle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe","family":"Atienza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Carta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Demelo-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,8]]},"reference":[{"key":"3710_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.698336","volume":"8","author":"D Duijzer","year":"2021","unstructured":"Duijzer D, de Winter MA, Nijkeuter M, Tuinenburg AE, Westerink J (2021) Upper extremity deep vein thrombosis and asymptomatic vein occlusion in patients with transvenous leads: a systematic review and meta-analysis. Front Cardiovasc Med 8:698336. https:\/\/doi.org\/10.3389\/fcvm.2021.698336","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"3710_CR2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1515\/rjim-2017-0018","volume":"55","author":"M Safi","year":"2017","unstructured":"Safi M, Akbarzadeh MA, Azinfar A, Namazi MH, Khaheshi I (2017) Upper extremity deep venous thrombosis and stenosis after implantation of pacemakers and defibrillators; a prospective study. Rom J Intern Med 55(3):139\u2013144. https:\/\/doi.org\/10.1515\/rjim-2017-0018","journal-title":"Rom J Intern Med"},{"issue":"5","key":"3710_CR3","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1177\/1129729818815135","volume":"20","author":"A Cacko","year":"2019","unstructured":"Cacko A, Kozyra-Pydy\u015b E, Gawa\u0142ko M, Opolski G, Grabowski M (2019) Predictors of venous stenosis or occlusion following first transvenous cardiac device implantation: prospective observational study. J Vasc Access 20(5):495\u2013500. https:\/\/doi.org\/10.1177\/1129729818815135","journal-title":"J Vasc Access"},{"issue":"1","key":"3710_CR4","first-page":"30","volume":"49","author":"J Ma","year":"2020","unstructured":"Ma J, Cui L, Huo W, Wang G, Quan X, Zhang J (2020) Correlation between deep venous thrombosis and inflammation in patients after implantation of permanent pacemaker. Iran J Public Health 49(1):30\u201336","journal-title":"Iran J Public Health"},{"key":"3710_CR5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejvs.2020.09.023","volume":"61","author":"SK Kakos","year":"2021","unstructured":"Kakos SK, Gohel M, Baekgaard N et al (2021) Clinical practice guideline document. European Society for Vascular Surgery (ESVS) clinical practice guidelines on the management of venous thrombosis. Eur J Vasc Endovasc Surg 61:9\u201382","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"4","key":"3710_CR6","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1177\/1358863X231175185","volume":"28","author":"MJ N\u00fa\u00f1ez-Fern\u00e1ndez","year":"2023","unstructured":"N\u00fa\u00f1ez-Fern\u00e1ndez MJ, Pad\u00edn-Paz EM, V\u00e1zquez-Temprano N, Nieto-Rodr\u00edguez JA, Marchena-Yglesias PJ, Imbalzano E et al (2023) The risk of recurrences in non-cancer patients with a symptomatic upper extremity deep vein thrombosis. Analysis of three RIETE cohorts. Vasc Med 28(4):324\u2013330. https:\/\/doi.org\/10.1177\/1358863X231175185","journal-title":"Vasc Med"},{"issue":"11","key":"3710_CR7","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1046\/j.1540-8167.2004.04081.x","volume":"15","author":"CJ Van Rooden","year":"2004","unstructured":"Van Rooden CJ, Molhoek SG, Rosendaal FR, Schalij MJ, Meinders AE, Huisman MV (2004) Incidence and risk factors of early venous thrombosis associated with permanent pacemarker leads. J Cardiovasc Electrophysiol 15(11):1258\u20131262","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"10","key":"3710_CR8","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1111\/j.1540-8159.2012.03467.x","volume":"35","author":"S Mandal","year":"2012","unstructured":"Mandal S, Pande A, Mandal D, Kumar A, Sarkar A, Kahali D et al (2012) Permanent pacemaker-related upper extremity deep vein thrombosis: a series of 20 cases. Pacing Clin Electrophysiol 35(10):1194\u20131198","journal-title":"Pacing Clin Electrophysiol"},{"key":"3710_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.thromres.2018.12.012","volume":"174","author":"K Thiyagarajah","year":"2019","unstructured":"Thiyagarajah K, Ellingwood L, Endres K, Hegazi A, Radford J, Iansavitchene A, Lazo-Langner A (2019) Post-thrombotic syndrome and recurrent thromboembolism in patients with upper extremity deep vein thrombosis: a systematic review and meta-analysis. Thromb Res 174:34\u201339. https:\/\/doi.org\/10.1016\/j.thromres.2018.12.012","journal-title":"Thromb Res"},{"issue":"2","key":"3710_CR10","doi-asserted-by":"publisher","first-page":"E131","DOI":"10.1532\/hsf.2291","volume":"22","author":"Z Xia","year":"2019","unstructured":"Xia Z, Yu J, Li J, Xiong Q, Tang Y, Yan S et al (2019) Pacemaker dysfunction due to a large thrombus on ventricular lead. Heart Surg Forum 22(2):E131\u2013E133. https:\/\/doi.org\/10.1532\/hsf.2291","journal-title":"Heart Surg Forum"},{"issue":"6","key":"3710_CR11","first-page":"714","volume":"37","author":"N Basar","year":"2010","unstructured":"Basar N, Cagli K, Basar O, Sem N, Gurel OM, Akpinar I et al (2010) Upper-extremity deep vein thrombosis and downhill esophageal varices caused by long-term pacemaker implantation. Tex Heart Inst J 37(6):714\u2013716","journal-title":"Tex Heart Inst J"},{"issue":"4","key":"3710_CR12","doi-asserted-by":"publisher","first-page":"316","DOI":"10.5811\/cpcem.2018.8.39444","volume":"2","author":"BA Mazer","year":"2018","unstructured":"Mazer BA, Hughes PG (2018) Pacemaker-associated phlegmasia cerulea dolens treated with catheter-directed thrombolysis. Clin Pract Cases Emerg Med 2(4):316\u2013319. https:\/\/doi.org\/10.5811\/cpcem.2018.8.39444","journal-title":"Clin Pract Cases Emerg Med"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-024-03710-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-024-03710-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-024-03710-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T00:07:57Z","timestamp":1728605277000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-024-03710-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,8]]},"references-count":12,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["3710"],"URL":"https:\/\/doi.org\/10.1007\/s11739-024-03710-8","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,8]]},"assertion":[{"value":"23 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Pablo Demelo-Rodr\u00edguez has received fees as a speaker from the following pharmaceutical companies: ROVI, Bayer, Techdow, Menarini, Leo Pharma, Pfizer, Bristol-Myers, Sanofi, and Daichii-Sankyo. In addition, he has been involved in advisory roles for Techdow, Leo Pharma, and Pfizer.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights statement and Informed consent"}}]}}